Skip to main content
Top
Published in: Journal of Neurology 1/2020

Open Access 01-01-2020 | Parkinson's Disease | Original Communication

Evolution of impulsive–compulsive behaviors and cognition in Parkinson’s disease

Authors: Aleksander H. Erga, Guido Alves, Ole Bjørn Tysnes, Kenn Freddy Pedersen

Published in: Journal of Neurology | Issue 1/2020

Login to get access

Abstract

The longitudinal course of ICBs in patients with Parkinson’s disease (PwP) relative to controls has not been explored as of yet. The aim of this study is to determine the frequency, evolution and associated cognitive and clinical features of impulsive and compulsive behaviors (ICBs) over 4 years of prospective follow-up in a population-based cohort with early Parkinson’s disease (PD). We recruited 124 cognitively intact participants with early PD and 156 matched controls from the Norwegian ParkWest study. ICBs were assessed using the self-report short form version of the Questionnaire for Impulsive–Compulsive Disorders in PD. Cognitive changes were examined in PwP with and without ICBs who completed the 4-year follow-up. Generalized linear mixed modelling and mixed linear regression were used to analyze clinical factors and cognitive changes associated with ICBs in PwP over time. ICBs were more common in PwP than controls at all visits, with an age-adjusted odds ratio (OR) varying between 2.5 (95% CI 1.1–5.6; p = 0.022) and 5.1 (95% CI 2.4–11.0; p < 0.001). The 4-year cumulative frequency of ICBs in PwP was 46.8% and 23.3% developed incident ICBs during the study period, but the presence of ICBs was non-persistent in nearly 30%. ICBs were independently associated with younger age (OR 0.95, 95% CI 0.91–0.99: p = 0.008) and use of dopamine agonist (OR 4.1, 95% CI 1.56–10.69). Cognitive changes over time did not differ between patients with and without ICBs. In conclusion, ICBs are common in PwP, but are often non-persistent and not associated with greater cognitive impairment over time.
Appendix
Available only for authorised users
Literature
1.
go back to reference Alves G, Muller B, Herlofson K, HogenEsch I, Telstad W, Aarsland D, Tysnes OB, Larsen JP, Norwegian ParkWest Study G (2009) Incidence of Parkinson's disease in Norway: the Norwegian ParkWest study. J Neurol Neurosurg Psychiatry 80:851–857CrossRef Alves G, Muller B, Herlofson K, HogenEsch I, Telstad W, Aarsland D, Tysnes OB, Larsen JP, Norwegian ParkWest Study G (2009) Incidence of Parkinson's disease in Norway: the Norwegian ParkWest study. J Neurol Neurosurg Psychiatry 80:851–857CrossRef
2.
go back to reference Antonini A, Barone P, Bonuccelli U, Annoni K, Asgharnejad M, Stanzione P (2017) ICARUS study: prevalence and clinical features of impulse control disorders in Parkinson's disease. J Neurol Neurosurg Psychiatry 88:317–324CrossRef Antonini A, Barone P, Bonuccelli U, Annoni K, Asgharnejad M, Stanzione P (2017) ICARUS study: prevalence and clinical features of impulse control disorders in Parkinson's disease. J Neurol Neurosurg Psychiatry 88:317–324CrossRef
3.
go back to reference Antonini A, Siri C, Santangelo G, Cilia R, Poletti M, Canesi M, Caporali A, Mancini F, Pezzoli G, Ceravolo R, Bonuccelli U, Barone P (2011) Impulsivity and compulsivity in drug-naive patients with Parkinson's disease. Mov Disord 26:464–468CrossRef Antonini A, Siri C, Santangelo G, Cilia R, Poletti M, Canesi M, Caporali A, Mancini F, Pezzoli G, Ceravolo R, Bonuccelli U, Barone P (2011) Impulsivity and compulsivity in drug-naive patients with Parkinson's disease. Mov Disord 26:464–468CrossRef
4.
go back to reference Bastiaens J, Dorfman BJ, Christos PJ, Nirenberg MJ (2013) Prospective cohort study of impulse control disorders in Parkinson's disease. Mov Disord 28:327–333CrossRef Bastiaens J, Dorfman BJ, Christos PJ, Nirenberg MJ (2013) Prospective cohort study of impulse control disorders in Parkinson's disease. Mov Disord 28:327–333CrossRef
5.
go back to reference Benton AL, Hamsher KD (1989) Multilingual aphasia examination. AJA Associates, Iowa City Benton AL, Hamsher KD (1989) Multilingual aphasia examination. AJA Associates, Iowa City
6.
go back to reference Claassen DO, van den Wildenberg WP, Ridderinkhof KR, Jessup CK, Harrison MB, Wooten GF, Wylie SA (2011) The risky business of dopamine agonists in Parkinson disease and impulse control disorders. Behav Neurosci 125:492–500CrossRef Claassen DO, van den Wildenberg WP, Ridderinkhof KR, Jessup CK, Harrison MB, Wooten GF, Wylie SA (2011) The risky business of dopamine agonists in Parkinson disease and impulse control disorders. Behav Neurosci 125:492–500CrossRef
7.
go back to reference Corvol JC, Artaud F, Cormier-Dequaire F, Rascol O, Durif F, Derkinderen P, Marques AR, Bourdain F, Brandel JP, Pico F, Lacomblez L, Bonnet C, Brefel-Courbon C, Ory-Magne F, Grabli D, Klebe S, Mangone G, You H, Mesnage V, Lee PC, Brice A, Vidailhet M, Elbaz A, Group DS (2018) Longitudinal analysis of impulse control disorders in Parkinson disease. Neurology 91:e189–e201CrossRef Corvol JC, Artaud F, Cormier-Dequaire F, Rascol O, Durif F, Derkinderen P, Marques AR, Bourdain F, Brandel JP, Pico F, Lacomblez L, Bonnet C, Brefel-Courbon C, Ory-Magne F, Grabli D, Klebe S, Mangone G, You H, Mesnage V, Lee PC, Brice A, Vidailhet M, Elbaz A, Group DS (2018) Longitudinal analysis of impulse control disorders in Parkinson disease. Neurology 91:e189–e201CrossRef
8.
go back to reference Delis DC, Kramer J, Ober BA (2000) CVLT-II. California verbal learning test, 2nd edn. Adult Version. The Psychological Corporation: Harcourt Assessment, Inc, San Antonio Delis DC, Kramer J, Ober BA (2000) CVLT-II. California verbal learning test, 2nd edn. Adult Version. The Psychological Corporation: Harcourt Assessment, Inc, San Antonio
9.
go back to reference Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A, Lees A, Levy R, Litvan I, McKeith I, Olanow W, Poewe W, Quinn N, Sampaio C, Tolosa E, Dubois B (2007) Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 22:1689–1707 (quiz 1837) CrossRef Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A, Lees A, Levy R, Litvan I, McKeith I, Olanow W, Poewe W, Quinn N, Sampaio C, Tolosa E, Dubois B (2007) Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 22:1689–1707 (quiz 1837) CrossRef
10.
go back to reference Erga AH, Alves G, Larsen JP, Tysnes OB, Pedersen KF (2017) Impulsive and compulsive behaviors in Parkinson's disease: the Norwegian ParkWest Study. J Parkinson's Dis 7:183–191CrossRef Erga AH, Alves G, Larsen JP, Tysnes OB, Pedersen KF (2017) Impulsive and compulsive behaviors in Parkinson's disease: the Norwegian ParkWest Study. J Parkinson's Dis 7:183–191CrossRef
11.
go back to reference Folstein MF, Folstein SE, McHugh PR (1975) Mini mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198CrossRef Folstein MF, Folstein SE, McHugh PR (1975) Mini mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198CrossRef
12.
go back to reference Golden CJ, Freshwater SM (1998) The stroop color and word test. The Stoelting Company, Wood Dale Golden CJ, Freshwater SM (1998) The stroop color and word test. The Stoelting Company, Wood Dale
13.
go back to reference Hollander E, Stein DJ (2006) Clinical manual of impulse-control disorders. American Psychiatric Association, Philadelphia Hollander E, Stein DJ (2006) Clinical manual of impulse-control disorders. American Psychiatric Association, Philadelphia
14.
go back to reference Hughes A, Daniel S, Kilford L, Lees A (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184CrossRef Hughes A, Daniel S, Kilford L, Lees A (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184CrossRef
15.
go back to reference Joutsa J, Martikainen K, Vahlberg T, Kaasinen V (2012) Effects of dopamine agonist dose and gender on the prognosis of impulse control disorders in Parkinson's disease. Parkinsonism Relat Disord 18:1079–1083CrossRef Joutsa J, Martikainen K, Vahlberg T, Kaasinen V (2012) Effects of dopamine agonist dose and gender on the prognosis of impulse control disorders in Parkinson's disease. Parkinsonism Relat Disord 18:1079–1083CrossRef
16.
go back to reference Mamikonyan E, Siderowf AD, Duda JE, Potenza MN, Horn S, Stern MB, Weintraub D (2008) Long-term follow-up of impulse control disorders in Parkinson's disease. Mov Disord 23:75–80CrossRef Mamikonyan E, Siderowf AD, Duda JE, Potenza MN, Horn S, Stern MB, Weintraub D (2008) Long-term follow-up of impulse control disorders in Parkinson's disease. Mov Disord 23:75–80CrossRef
18.
go back to reference Martini A, Dal Lago D, Edelstyn NMJ, Salgarello M, Lugoboni F, Tamburin S (2018) Dopaminergic neurotransmission in patients with Parkinson's disease and impulse control disorders: a systematic review and meta-analysis of PET and SPECT studies. Front Neurol 9:1018CrossRef Martini A, Dal Lago D, Edelstyn NMJ, Salgarello M, Lugoboni F, Tamburin S (2018) Dopaminergic neurotransmission in patients with Parkinson's disease and impulse control disorders: a systematic review and meta-analysis of PET and SPECT studies. Front Neurol 9:1018CrossRef
19.
go back to reference Molde H, Moussavi Y, Kopperud ST, Erga AH, Hansen AL, Pallesen S (2018) Impulse-control disorders in Parkinson's disease: a meta-analysis and review of case–control studies. Front Neurol 9:330CrossRef Molde H, Moussavi Y, Kopperud ST, Erga AH, Hansen AL, Pallesen S (2018) Impulse-control disorders in Parkinson's disease: a meta-analysis and review of case–control studies. Front Neurol 9:330CrossRef
20.
go back to reference Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382–389CrossRef Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382–389CrossRef
21.
go back to reference Okai D, Askey-Jones S, Samuel M, David AS, Brown RG (2015) Predictors of response to a cognitive behavioral intervention for impulse control behaviors in Parkinson's disease. Mov Disord 30:736–739CrossRef Okai D, Askey-Jones S, Samuel M, David AS, Brown RG (2015) Predictors of response to a cognitive behavioral intervention for impulse control behaviors in Parkinson's disease. Mov Disord 30:736–739CrossRef
22.
go back to reference Okai D, Askey-Jones S, Samuel M, O'Sullivan SS, Chaudhuri KR, Martin A, Mack J, Brown RG, David AS (2013) Trial of CBT for impulse control behaviors affecting Parkinson patients and their caregivers. Neurology 80:792–799CrossRef Okai D, Askey-Jones S, Samuel M, O'Sullivan SS, Chaudhuri KR, Martin A, Mack J, Brown RG, David AS (2013) Trial of CBT for impulse control behaviors affecting Parkinson patients and their caregivers. Neurology 80:792–799CrossRef
23.
go back to reference Papay K, Mamikonyan E, Siderowf AD, Duda JE, Lyons KE, Pahwa R, Driver-Dunckley ED, Adler CH, Weintraub D (2011) Patient versus informant reporting of ICD symptoms in Parkinson's disease using the QUIP: validity and variability. Parkinsonism Relat Disord 17:153–155CrossRef Papay K, Mamikonyan E, Siderowf AD, Duda JE, Lyons KE, Pahwa R, Driver-Dunckley ED, Adler CH, Weintraub D (2011) Patient versus informant reporting of ICD symptoms in Parkinson's disease using the QUIP: validity and variability. Parkinsonism Relat Disord 17:153–155CrossRef
24.
go back to reference Rabinak C, Nirenberg MJ (2010) Dopamine agonist withdrawal syndrome in Parkinson disease. Arch Neurol 67:58–63CrossRef Rabinak C, Nirenberg MJ (2010) Dopamine agonist withdrawal syndrome in Parkinson disease. Arch Neurol 67:58–63CrossRef
25.
go back to reference Rosenberg KP, Feder LC (2014) Behavioral addictions—criteria, evidence and treatment. Academic Press, San Diego Rosenberg KP, Feder LC (2014) Behavioral addictions—criteria, evidence and treatment. Academic Press, San Diego
26.
go back to reference Santangelo G, Raimo S, Barone P (2017) The relationship between impulse control disorders and cognitive dysfunctions in Parkinson's Disease: a meta-analysis. Neurosci Biobehav Rev 77:129–147CrossRef Santangelo G, Raimo S, Barone P (2017) The relationship between impulse control disorders and cognitive dysfunctions in Parkinson's Disease: a meta-analysis. Neurosci Biobehav Rev 77:129–147CrossRef
27.
go back to reference Siri C, Cilia R, Reali E, Pozzi B, Cereda E, Colombo A, Meucci N, Canesi M, Zecchinelli AL, Tesei S, Mariani CB, Sacilotto G, Zini M, Pezzoli G (2015) Long-term cognitive follow-up of Parkinson's disease patients with impulse control disorders. Mov Disord 30:696–704CrossRef Siri C, Cilia R, Reali E, Pozzi B, Cereda E, Colombo A, Meucci N, Canesi M, Zecchinelli AL, Tesei S, Mariani CB, Sacilotto G, Zini M, Pezzoli G (2015) Long-term cognitive follow-up of Parkinson's disease patients with impulse control disorders. Mov Disord 30:696–704CrossRef
29.
go back to reference Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 25:2649–2653CrossRef Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 25:2649–2653CrossRef
30.
go back to reference Voon V, Gao J, Brezing C, Symmonds M, Ekanayake V, Fernandez H, Dolan RJ, Hallett M (2011) Dopamine agonists and risk: impulse control disorders in Parkinson's disease. Brain J Neurol 134:1438–1446CrossRef Voon V, Gao J, Brezing C, Symmonds M, Ekanayake V, Fernandez H, Dolan RJ, Hallett M (2011) Dopamine agonists and risk: impulse control disorders in Parkinson's disease. Brain J Neurol 134:1438–1446CrossRef
31.
go back to reference Voon V, Sohr M, Lang AE, Potenza MN, Siderowf AD, Whetteckey J, Weintraub D, Wunderlich GR, Stacy M (2011) Impulse control disorders in Parkinson disease: a multicenter case–control study. Ann Neurol 69:986–996CrossRef Voon V, Sohr M, Lang AE, Potenza MN, Siderowf AD, Whetteckey J, Weintraub D, Wunderlich GR, Stacy M (2011) Impulse control disorders in Parkinson disease: a multicenter case–control study. Ann Neurol 69:986–996CrossRef
32.
go back to reference Warrington EK, James M (1991) The visual object and space perception battery. Thames Valley Test Company, Bury St Edmunds Warrington EK, James M (1991) The visual object and space perception battery. Thames Valley Test Company, Bury St Edmunds
33.
go back to reference Weintraub D, Hoops S, Shea JA, Lyons KE, Pahwa R, Driver-Dunckley ED, Adler CH, Potenza MN, Miyasaki J, Siderowf AD, Duda JE, Hurtig HI, Colcher A, Horn SS, Stern MB, Voon V (2009) Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease. Mov Disord 24:1461–1467CrossRef Weintraub D, Hoops S, Shea JA, Lyons KE, Pahwa R, Driver-Dunckley ED, Adler CH, Potenza MN, Miyasaki J, Siderowf AD, Duda JE, Hurtig HI, Colcher A, Horn SS, Stern MB, Voon V (2009) Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease. Mov Disord 24:1461–1467CrossRef
34.
go back to reference Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy M, Voon V, Whetteckey J, Wunderlich GR, Lang AE (2010) Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 67:589–595CrossRef Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy M, Voon V, Whetteckey J, Wunderlich GR, Lang AE (2010) Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 67:589–595CrossRef
35.
go back to reference Wu K, Politis M, Piccini P (2009) Parkinson disease and impulse control disorders: a review of clinical features, pathophysiology and management. Postgrad Med J 85:590–596CrossRef Wu K, Politis M, Piccini P (2009) Parkinson disease and impulse control disorders: a review of clinical features, pathophysiology and management. Postgrad Med J 85:590–596CrossRef
36.
go back to reference Zhang S, Dissanayaka NN, Dawson A, O'Sullivan JD, Mosley P, Hall W, Carter A (2016) Management of impulse control disorders in Parkinson's disease. Int Psychogeriatr 28:1597–1614CrossRef Zhang S, Dissanayaka NN, Dawson A, O'Sullivan JD, Mosley P, Hall W, Carter A (2016) Management of impulse control disorders in Parkinson's disease. Int Psychogeriatr 28:1597–1614CrossRef
Metadata
Title
Evolution of impulsive–compulsive behaviors and cognition in Parkinson’s disease
Authors
Aleksander H. Erga
Guido Alves
Ole Bjørn Tysnes
Kenn Freddy Pedersen
Publication date
01-01-2020
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 1/2020
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-019-09584-7

Other articles of this Issue 1/2020

Journal of Neurology 1/2020 Go to the issue